BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19624902)

  • 1. [Effect of vaginal administration of controlled-release oxycodone on cancer pain].
    Zhang X; Ruan XJ; Liu C; Yu ZH
    Ai Zheng; 2009 Jul; 28(7):740-2. PubMed ID: 19624902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.
    Pan H; Zhang Z; Zhang Y; Xu N; Lu L; Dou C; Guo Y; Wu S; Yue J; Wu D; Dai Y
    Clin Drug Investig; 2007; 27(4):259-67. PubMed ID: 17358098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
    Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
    J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
    Silvestri B; Bandieri E; Del Prete S; Ianniello GP; Micheletto G; Dambrosio M; Sabbatini G; Endrizzi L; Marra A; Aitini E; Calorio A; Garetto F; Nastasi G; Piantedosi F; Sidoti V; Spanu P
    Clin Drug Investig; 2008; 28(7):399-407. PubMed ID: 18544000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
    J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.
    Hale ME; Fleischmann R; Salzman R; Wild J; Iwan T; Swanton RE; Kaiko RF; Lacouture PG
    Clin J Pain; 1999 Sep; 15(3):179-83. PubMed ID: 10524470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery.
    Reuben SS; Connelly NR; Maciolek H
    Anesth Analg; 1999 Jun; 88(6):1286-91. PubMed ID: 10357331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release oxycodone and morphine in cancer related pain.
    Heiskanen T; Kalso E
    Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.
    Palangio M; Morris E; Doyle RT; Dornseif BE; Valente TJ
    Clin Ther; 2002 Jan; 24(1):87-99. PubMed ID: 11833838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?
    Salzman RT; Roberts MS; Wild J; Fabian C; Reder RF; Goldenheim PD
    J Pain Symptom Manage; 1999 Oct; 18(4):271-9. PubMed ID: 10534967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G; Xiang J; Biondi D; Upmalis D; Delfgaauw J; Allard R; Moskovitz B
    Pain Res Manag; 2011; 16(4):245-51. PubMed ID: 22059194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic efficacy of controlled-release oxycodone in postoperative pain.
    Sunshine A; Olson NZ; Colon A; Rivera J; Kaiko RF; Fitzmartin RD; Reder RF; Goldenheim PD
    J Clin Pharmacol; 1996 Jul; 36(7):595-603. PubMed ID: 8844441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.